Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,055,585    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,994,434      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $886,974 Immunome Inc. $140,571 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $886,974 Immunome Inc. $140,571
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 31 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-06 4 OE $37.46 $749,200 D/D 20,000 355,324 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-11 4 AS $90.99 $1,819,800 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-11 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-12 4 AS $91.26 $1,825,200 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-12 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-09 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-09 4 AS $81.62 $1,632,400 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-10 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-10 4 AS $81.14 $1,622,800 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-02-29 4 S $37.91 $805,798 D/D (21,142) 4,071 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-04-27 4 AS $34.66 $769,872 D/D (22,000) 112,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 OE $6.46 $145,647 I/I 22,546 55,804 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 AS $120.53 $2,717,546 I/I (22,546) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 AS $114.98 $2,669,517 I/I (23,218) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 OE $6.46 $149,988 I/I 23,218 56,476 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-15 4 D $78.39 $1,836,364 D/D (23,426) 313,576 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-11 4 OE $6.46 $212,500 D/D 25,000 194,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 OE $12.99 $324,750 I/I 25,000 45,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 S $70.74 $1,773,551 I/I (25,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-06 4 AS $78.01 $1,957,199 D/D (25,000) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-06 4 OE $26.49 $662,250 D/D 25,000 328,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-07 4 AS $77.60 $1,953,121 D/D (25,000) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-07 4 OE $26.49 $662,250 D/D 25,000 328,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-11 4 S $38.01 $969,656 D/D (25,500) 168,691 0 -
IMUX Immunic Inc Director   –       •      –    2018-09-24 4 S $0.30 $8,002 D/D (26,619) 18,500 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  32   33   34   35      
  Page 31 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us